Status:

RECRUITING

Women's Wellbeing Study

Lead Sponsor:

Butler Hospital

Collaborating Sponsors:

National Center for Complementary and Integrative Health (NCCIH)

Conditions:

Distress, Psychological

Eligibility:

FEMALE

18-65 years

Phase:

NA

Brief Summary

Phase 2 is a randomized controlled trial of integrative yoga and mindful self-compassion program vs. women's wellbeing education for women with a history of interpersonal violence exposure and heighte...

Detailed Description

In Phase 2, the investigators will conduct a pilot randomized controlled trial (RCT) of 12 weeks of integrative yoga and mindful self-compassion training (I-YMSC) vs. 12 weeks of women's wellbeing edu...

Eligibility Criteria

Inclusion

  • Female
  • Ages 18-65
  • Report having experienced interpersonal violence (defined to include all forms throughout the lifespan, confirmed with the Trauma History Questionnaire (THQ\])
  • Report being distressed, defined by a score of \>5 on the Kessler-6 screener
  • Speak and understand English well enough to understand questionnaires when they are read aloud
  • Have access to a telephone through owning one, a relative/friend, or an agency
  • Have access to a device that will support use of the video platform we are using to conduct assessments and for home practice yoga video sessions

Exclusion

  • Inability to be physically active, determined by a score \>1 on the Physical Activity Readiness Questionnaire (PAR-Q) and physician non-consent of participation
  • Planned surgery in next 6 months, as this would interfere with study participation
  • Pregnancy, as yoga should be modified for pregnancy
  • Women who meet criteria for the following:
  • Current mania as determined by the Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND)
  • Lifetime history of psychotic disorders (DIAMOND)
  • Current probable severe substance use disorder (DIAMOND)
  • Current diagnosis of anorexia nervosa or history in past year (DIAMOND)
  • Moderate or high risk for suicide on the adapted Columbia Suicide Severity Rating Scale screen version-recent (C-SSRS) and/or endorsement of suicidal plan/intent in the past 3 months
  • Non-stable course of psychiatric treatments (medication, psychotherapy) for the last 8 weeks
  • Plan to move from the area in the next 6 months, as this may preclude study participation given enrollment timeframes
  • Self-report of experiencing intimate partner violence currently or within past six months (assessed by the Revised Conflict Tactics Scale 2 \[R-CTS2\]), as this would require a different type of intervention
  • Current weekly yoga practice or current participation in mindfulness-based programming, as these are the study interventions

Key Trial Info

Start Date :

August 27 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 31 2027

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT07195019

Start Date

August 27 2025

End Date

May 31 2027

Last Update

September 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Butler Hospital

Providence, Rhode Island, United States, 02906